Senior Manager, Clinical Biomarker Operations
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
As a Senior Manager, Clinical Biomarker Operations (CBO) within the Translational Medicine function, you will provide biomarker operational expertise, develop scope of work (SOW), and maintain effective working relationships with cross-functional teams supporting Phase I–III clinical trials.
-
Operationalize the biomarker program strategies in clinical trials to support early- and late-stage development of portfolio assets.
